preventative care. definitive results.

About Us

Continuous Precision Medicine™ is a leader in the fight against the opioid epidemic.  

We are engineering tools and services to combat one of the most costly and emotionally damaging issues in healthcare, opioid addiction.

Meet The Team

  • team
    Steven K. Walther, MBA Chief Executive Officer & Co-Founder
    Steven, an inventor and successful entrepreneur, is medically trained and has over a decade of healthcare related experience. He attended Campbell University, earning a Master of Business Administration and John F. Kennedy Special Warfare Center & School, earning a Green Beret. Steven is especially driven in his work with CPM, as he fought against this very issue of opioid addiction while serving in Afghanistan.
  • team
    Steven T. Szabo, MD, PhD Director of Research & Development
    Dr. Szabo is a neuroscientist and psychiatrist with a specialization in psychopharmacology and experimental therapeutics. He completed his PhD at McGill University, postdoctoral training at the National Institutes of Health, and psychiatry residency at Duke University. Dr. Szabo employs a translational approach to developing therapeutics with greater efficacy in disorders such as depression, anxiety, posttraumatic stress disorder, and substance abuse. He uses novel biomarker approaches in clinical trial design as a measure of neural circuit modulation and target engagement to testing of experimental drugs and devices.
  • team
    Barry L. Jenkins, MD Chairman of the Board & Founder
    Dr. Jenkins received his medical degree from Harvard Medical School and completed post graduate training in Anesthesiology at the University of Pennsylvania. He practiced in his home town of Pottsville, Pennsylvania for 28 years as the Chairman of the Department of Anesthesiology and Pain Management of Pottsville Hospital, later Schuylkill Health. Dr. Jenkins also served as a clinical instructor for the University of Scranton Anesthesia post-graduate training program, where he taught practical clinical pharmacokinetic and pharmacodynamic methods of opioid narcotic management. He is a diplomat of the American Board of Anesthesiology.
  • team
    Donald R. Gintzig, MBA Board Member & Advisor
    Mr. Gintzig is the Chief Executive Officer and President at WakeMed Health & Hospitals, Inc. He also served as Rear Admiral, Deputy Chief, Bureau of Medicine and Surgery, in the United States Navy and as Senior Vice President with UnitedHealth Group. Mr. Gintzig has over 25 years of experience as a senior healthcare executive. He is a member of the American College of Health Care Executives. Mr. Gintzig received his Bachelor’s and Master of Business Administration degrees from George Washington University, Washington, D. C.
  • team
    Jerry Heneghan, MBA Board Member & Advisor
    Jerry Heneghan is Professor of the Practice and Director, UNC Center for Innovation in Pharmacy Simulation (CIPS) at the UNC Eshelman School of Pharmacy in Chapel Hill, North Carolina. Heneghan leads CIPS in the development of advanced simulation tools to enhance all phases of education and pharmaceutical research including medication discovery, delivery, optimization, assessment, and practice. Heneghan is also the Chief Design Officer for BioMojo LLC, a woman-owned small business, focused on the development of biomedical performance solutions. Heneghan is a former U.S. Army Aviator and holds an M.B.A. from the Fuqua School of Business at Duke University and a B.S. in engineering from the United States Military Academy.
  • team
    Jeff E. Mandel, MD Advisor
    Dr. Mandel specializes in anesthesiology at the University of Pennsylvania. He has been practicing in the medical field for 36 years upon earning his degree from the University of Texas Southwestern Medical School.


Substance dependence: Assessment and initial intervention
Where people are not severely alcohol or drug dependent, brief interventions can result in substantial reductions in use and levels of risk.
Opioid Abuse Prevention Bill Clears House
RALEIGH, N.C. — A proposal to reduce opioid misuse in North Carolina was on its way to the state Senate Monday night after winning unanimous approval in the House, 114-0.
America's Opioid Epidemic
Inside America's growing struggle with opioid painkillers and heroin addiction
With a 10-day supply of opioids, 1 in 5 become long-term users
The longer a person uses opioids, the greater the risk of forming a deadly addiction. But just how long does it take to switch from being a short-term user—say, while you’re dealing with pain after a surgery—to a long-term, potentially problematic user? A few weeks? A month?
Obama Seeks More Than $1 Billion to Fight Opioid Abuse
WASHINGTON — The Obama administration said on Tuesday that it would ask Congress to spend an additional $1.1 billion next year to combat a growing epidemic of prescription painkiller and heroin abuse.

Contact Us

Have a question? Want to join the team? Have a great idea for us?  
  Send Message
© Continuous Precision Medicine 2019